SCND director exercises 15,000 warrants; ownership 90,778 shares

Scientific Industries, Inc. (SCND) reporting person John J. Nicols, a director, exercised 15,000 warrants on 08/20/2025 at an exercise price of $1.00 per share.

Rhea-AI Filing Summary

Scientific Industries, Inc. (SCND) reporting person John J. Nicols, a director, exercised 15,000 warrants on 08/20/2025 at an exercise price of $1.00 per share. The exercise converted the warrants into 15,000 shares of common stock, increasing the reporting person's total beneficial ownership to 90,778 shares. The filing indicates the transaction was a direct acquisition and does not disclose any concurrent sale of the shares. The signed Form 4 was dated 10/06/2025.

Positive

• Director increased ownership by exercising 15,000 warrants at $1.00
• Post-transaction beneficial ownership is 90,778 shares, showing continued insider stake

Negative

• Share issuance from exercise increases outstanding shares, causing potential dilution to existing holders

Insights

Corporate Governance Expert

Director exercised warrants, modestly increasing insider stake.

The reporting person exercised 15,000 warrants at $1.00, creating immediate ownership of 90,778 shares. This is a direct acquisition that aligns the director's economic exposure with other shareholders.

Key dependencies include the total outstanding share count and any subsequent share sales; the filing shows no sale. Watch near-term insider selling disclosures and periodic Section 16 filings for changes within Q4 2025.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 1 txn

Insider NICOLS JOHN J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	15,000	$1.00	$15K

Holdings After Transaction: Common Stock — 90,778 shares (Direct)

Footnotes (1)

1. F1. On August 20, 2025 15,000 warrants for 15,000 shares of the Company's common stock were exercised at $1.00 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SCND director John J. Nicols do on 08/20/2025?

He exercised 15,000 warrants into 15,000 common shares at an exercise price of $1.00 per share.

How many SCND shares does John J. Nicols beneficially own after the transaction?

The filing reports 90,778 shares of common stock beneficially owned following the exercise.

Was the Form 4 filed jointly or by one reporting person?

The form was filed by one reporting person (individual filing).

Did the Form 4 disclose any sale of the shares after exercise?

No sale was disclosed; the transaction is recorded as an A (acquisition) and the ownership form is direct.

What price was paid to exercise the warrants?

The exercise price reported is $1.00 per warrant/share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/06/2025 - 12:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NICOLS JOHN J

(Last) (First) (Middle)

ALBEMARLE CORP

451 FLORIDA ST

(Street)

BATON ROUGE LA 70801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025	08/20/2025	A		15,000	A	$1(1)	90,778	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 20, 2025 15,000 warrants for 15,000 shares of the Company's common stock were exercised at $1.00 per share.

	John Nicols	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.